Status:
COMPLETED
Atomoxetine Effects in Humans
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Physiological Stress
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
PHASE2
Brief Summary
A total of 18 healthy volunteers will participate in this four-week, within-groups, double-blind, placebo-controlled study. The study has two phases separated by a 4 to 15-day washout period. Subjects...
Detailed Description
This pilot study will examine the effects of a norepinephrine reuptake blocker, atomoxetine, on physiological and subjective responses to physical and psychological models of stress and oral amphetami...
Eligibility Criteria
Inclusion
- Female and males age 18 yrs to 45 yrs
- Current history of good health and normal ECG
- not pregnant , nor breast feeding
- using acceptable birth control methods
Exclusion
- History of heart disease, hypertension, renal or hepatic diseases, glaucoma,hyperthyroidism,
- Current use of psychotropic medication
- Current dependence on alcohol or on drugs or treatments for drug or alcohol addiction within the past 5 years
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00607568
Start Date
June 1 2006
End Date
September 1 2009
Last Update
December 12 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.